Hyderabad: As part of its expansion of its commercial operations in Europe, Dr Reddy’s Laboratories Ltd launched portfolio of generics in France. The products will be made available in the hospital market in March this year in the area of oncology and anti-infectives, including antimycotics.

The company recently launched select products of its hospital portfolio in Italy and Spain, and is looking to further strengthen its presence in those two countries with the launch of anti-HIV products this year, according to a company’s statement.